CStone Raises $260 million in Series B Financing to Advance Novel Cancer Therapies
SUZHOU, China, May 9, 2018 /PRNewswire/ — CStone Pharmaceuticals (“CStone”) announced today the successful completion of a $260 million (about RMB1.65 billion) financing, the largest Series B funding in the…
CEDRUS Investments WILL launch a new office in Shenzhen
Expanding its Footprint in the Greater China Region and Capitalizing on Life Sciences Innovation and Hi-tech Investment Opportunities HONG KONG, May 9, 2018 /PRNewswire/ — Cedrus Investments (“Cedrus”), a global…
Ortho Clinical Diagnostics Holds Summit to Help Asia-Pacific Lab Leaders Envision the Lab of the Future
RARITAN, New Jersey and SINGAPORE, May 8, 2018 /PRNewswire/ — Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, will host the Ortho Lab Leader Scientific Summit on…
WuXi AppTec Announces Listing of Initial Public Offering of Common Stock on Shanghai Stock Exchange
SHANGHAI, May 8, 2018 /PRNewswire/ — WuXi AppTec Co., Ltd. (“WuXi AppTec” or “the Company”; Stock Code: 603259), a leading global pharmaceutical and medical device open-access capability and technology platform…
WuXi STA Changzhou Site Passes First U.S. FDA Inspection
The integrated R&D and manufacturing facility is expecting more products to go into commercial production post approval SHANGHAI, May 7, 2018 /PRNewswire/ — STA Pharmaceutical Co., Ltd., (WuXi STA), a…
Vieworks’ VIVIX-S N Series Receives CFDA Clearance
-By strengthening the wireless X-ray flat panel detector lineup, Vieworks is expecting to revamp sales in China ANYANG, South Korea and BEIJING, May 7, 2018 /PRNewswire/ — China Food and…
Mundipharma licenses Starpharma’s VivaGel BV
– Mundipharma licenses Starpharma’s VivaGel® BV for Asia, Middle East, Africa and the majority of Latin America, to be marketed as part of the popular BETADINE® Feminine Care portfolio –…
CStone announces first patient dosed with anti-CTLA-4 antibody CS1002 of a Phase I study in Australia
SUZHOU, China, May 4, 2018 /PRNewswire/ — CStone Pharmaceuticals (Suzhou) Co., Ltd., (CStone) today announced dosing of the first patient of a Phase I clinical trial in Australia for CS1002,…
VolitionRx Limited Schedules First Quarter 2018 Earnings Conference Call and Business Update
Conference call to take place Friday, May 11, 2018 at 8:30 am Eastern time ISNES, Belgium, May 4, 2018 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced it…
China Biologic Reports Financial Results for the First Quarter of 2018
–1Q18 Total Sales Up 13.7% YoY and Non-GAAP Adjusted Net Income Up 2.1% YoY in RMB terms, or Total Sales Up 23.0% YoY to $112.5 Million and Net Income Up…
